SNMMI updates guidelines on PSMA-PET imaging
May 13, 2022 -- The Society for Nuclear Medicine and Molecular Imaging (SNMMI) is now considering all PSMA-PET radiotracers for detecting prostate cancer -- whether approved or not -- as equivalent, and it will refer to them as a class ("PSMA PET"), according to a recent update of the society's Appropriate Use Criteria. Read More
Video from ISMRM 2022: Why Nandita deSouza loves the congress
May 10, 2022 -- LONDON - Radiologist and cancer imaging expert Nandita deSouza, PhD, has attended nearly every annual meeting of the International Society for Magnetic Resonance in Medicine (ISMRM) since 1991. In this interview, she explains why she returns year after year. Read More
PET/CT reveals heart artery inflammation in COVID-19 patients
May 6, 2022 -- PET/CT imaging shows that inflammation of the aorta is increased in the early postinfection stage of COVID-19 in patients with severe disease, according to a study published May 2 in the Journal of Nuclear Cardiology. Read More
Imaging criteria helps pick best patients for Pluvicto treatment
May 3, 2022 -- What's the best way to pick which patients should receive treatment with Pluvicto, a recently approved radiopharmaceutical therapy for metastatic prostate cancer? Imaging criteria can help select the best candidates, according to a presentation May 2 at the American Roentgen Ray Society meeting in New Orleans. Read More
Use of V/Q scans dropped during COVID-19 pandemic
May 3, 2022 -- Nuclear medicine ventilation/perfusion scintigraphy (V/Q) dropped significantly during the COVID-19 pandemic, as hospitals took up new protocols to reduce the chances of infections, according to an abstract presented at the American Roentgen Ray Society meeting in New Orleans. Read More
PET tracer shows promise imaging high cholesterol activity
May 2, 2022 -- A new PET radiotracer is safe for humans and could provide a noninvasive approach for diagnosing aldosteronism, a condition linked to high cholesterol and heart disease, according to a study published April 28 in the Journal of Nuclear Medicine. Read More
PET-based model may help stage Alzheimer's disease patients
April 28, 2022 -- Researchers have developed a new model for diagnosing the severity of Alzheimer's disease in patients based largely on the spatial topography of brain PET imaging, according to a study published April 25 in Nature Aging. Read More
PET superior to MRI for meningioma treatment planning
April 25, 2022 -- PET imaging with a gallium-68 (Ga-68)-based radiotracer is more precise than standard MRI for detecting meningiomas targeted for radiotherapy, according to a study published April 20 in the International Journal of Radiation, Oncology, Biology, Physics. Read More
Midtherapy PET/CT predicts response in patients with esophageal cancer
April 22, 2022 -- Performing PET/CT scans while patients are undergoing radiotherapy prior to surgery for esophageal cancer can help predict whether they will respond to treatment, according to a study published April 18 in Radiotherapy and Oncology. Read More
Dual-tracer PET/CT shows promise in cancer imaging
April 20, 2022 -- Two PET/CT radiotracers -- F-18 FDG and gallium-68 FAPI-46 -- work better together than when used alone for cancer imaging, according to a proof-of-concept study published April 14 in the Journal of Nuclear Medicine. Read More